Analysts have been eager to weigh in on the Healthcare sector with new ratings on Tecan Group AG (TCHBF – Research Report) and Amarin (AMRN – Research Report).
Tecan Group AG (TCHBF)
In a report issued on January 9, Maja Pataki from Kepler Capital maintained a Buy rating on Tecan Group AG, with a price target of CHF395.00. The company’s shares closed last Tuesday at $381.00.
Pataki has an average return of
According to TipRanks.com, Pataki is ranked #8537 out of 8658 analysts.
Currently, the analyst consensus on Tecan Group AG is a Strong Buy with an average price target of $446.60, representing a 17.2% upside. In a report issued on January 3, Baader Bank also maintained a Buy rating on the stock with a CHF400.00 price target.
See the top stocks recommended by analysts >>
Amarin (AMRN)
Goldman Sachs analyst Paul Choi maintained a Sell rating on Amarin yesterday and set a price target of $1.00. The company’s shares closed last Wednesday at $1.29.
According to TipRanks.com, Choi is a 5-star analyst with an average return of
Currently, the analyst consensus on Amarin is a Moderate Sell with an average price target of $1.33.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on TCHBF:
